Terns Pharmaceuticals Gross Profit

Terns Pharmaceuticals (TERN) currently reports a gross profit of $0 as of December 2025. That compares with $-480K in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of $65B. Use the charts on this page to explore Terns Pharmaceuticals's gross profit history and peer comparisons.

Terns Pharmaceuticals's gross profit increased from $-480K to $0 — a 100.0% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Terns Pharmaceuticals's gross profit of $0 is lower than the Healthcare sector average of $65B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Terns Pharmaceuticals reported $0 in gross profit as of December 2025. That compares with $-480K in the prior-year period — up 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $65B. From there, open related valuation or income-statement pages for Terns Pharmaceuticals, and consider following TERN for alerts when major investors trade the stock.